Your browser doesn't support javascript.
loading
Clinical Efficacy and Safety of Intravenous levofloxacin in Patients of Abdominal Operati / 한국간담췌외과학회지
Article in Ko | WPRIM | ID: wpr-153648
Responsible library: WPRO
ABSTRACT
BACKGROUND/AIMS: For the investigation of the efficacy and safety of intravenous levofloxacin, The clinical study was carrried out in 30 patients with abdominal operation, especially in hepatobiliary and pancreatic division. METHODS: Randomly chosen patients received intravenous levofloxacin (250mg bid) for only 7 days. Clinical and microbiological evaluation were conducted on the day of starting and finishing levofloxacin treatmeat except for the case of combined use of antibiotics. RESULTS: The most commonly isolated organism was staphylococcus aureus(33%, 3/9). The overall bacteriologic eradication rate was 67%, (6/9) with clinical success rate was 96%(29/30), There were no significant dverse effects to stop the administration of the drug. CONCLUSION: These results suggest that intravenous levofloxacin is effective and safe antibiotics in the fields management of abdominal operation especially in hepatobiliary and pancreas surgery.
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Pancreas / Staphylococcus / Levofloxacin / Anti-Bacterial Agents Limits: Humans Language: Ko Journal: Korean Journal of Hepato-Biliary-Pancreatic Surgery Year: 2001 Type: Article
Full text: 1 Index: WPRIM Main subject: Pancreas / Staphylococcus / Levofloxacin / Anti-Bacterial Agents Limits: Humans Language: Ko Journal: Korean Journal of Hepato-Biliary-Pancreatic Surgery Year: 2001 Type: Article